Modulators of HIF1a and NFkB in Cancer treatment: Is it a rational approach for controlling malignant progression?

by Marco eTafani, Marco eTafani, Bruna ePucci, Andrea eRusso, Luana eSchito, Laura ePellegrini, Laura ePellegrini, Giulietta A Perrone, Lidia eVillanova, Lidia eVillanova, Luisa eSalvatori, Linda eRavenna, Elisa ePetrangeli, Elisa ePetrangeli, Matteo A Russo
Published 2013-02-01